Ethoheptazine Free Base

    WARNING: This product is for research use only, not for human or veterinary use.

Hodoodo CAT#: H414110

CAS#: 77-15-6 (free base)

Description: Ethoheptazine Free Base is an opioid analgesic from the phenazepane family. It was invented in the 1950s and is a ring expanded analogue of pethidine. Ethoheptazine produces similar effects to other opioids, including analgesia, sedation, dizziness and nausea.


Chemical Structure

img
Ethoheptazine Free Base
CAS# 77-15-6 (free base)

Theoretical Analysis

Hodoodo Cat#: H414110
Name: Ethoheptazine Free Base
CAS#: 77-15-6 (free base)
Chemical Formula: C16H23NO2
Exact Mass: 261.17
Molecular Weight: 261.370
Elemental Analysis: C, 73.53; H, 8.87; N, 5.36; O, 12.24

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Related CAS #: 77-15-6 (free base)   6700-56-7 (citrate)  

Synonym: Ethoheptazine Free Base; HSDB3326; HSDB-3326; HSDB 3326

IUPAC/Chemical Name: Azepine-4-carboxylic acid, hexahydro-1-methyl-4-phenyl-, ethyl ester

InChi Key: WGJHHMKQBWSQIY-UHFFFAOYSA-N

InChi Code: InChI=1S/C16H23NO2/c1-3-19-15(18)16(14-8-5-4-6-9-14)10-7-12-17(2)13-11-16/h4-6,8-9H,3,7,10-13H2,1-2H3

SMILES Code: O=C(C1(C2=CC=CC=C2)CCN(C)CCC1)OCC

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: To be determined

Shelf Life: >2 years if stored properly

Drug Formulation: To be determined

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 261.37 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Sinclair JG. Ethoheptazine-monoamine oxidase inhibitor interaction in rabbits. Can J Physiol Pharmacol. 1972 Sep;50(9):923-6. doi: 10.1139/y72-132. PMID: 4678166.

2: Leander JD. Effects of propoxyphene, ethoheptazine, and azabicyclane on schedule-controlled responding: attenuation by pentobarbital but not naloxone. Psychopharmacology (Berl). 1979;66(1):19-22. doi: 10.1007/BF00431983. PMID: 44372.

3: Scheiner JJ, Richards DJ. Treatment of musculoskeletal pain and associated anxiety with an ethoheptazine-aspirin-meprobamate combination (equagesic): a controlled study. Curr Ther Res Clin Exp. 1974 Sep;16(9):928-36. PMID: 4214668.

4: Sweetman BJ, Baig A, Parsons DL. Mefenamic acid, chlormezanone-paracetamol, ethoheptazine-aspirin-meprobamate: a comparative study in acute low back pain. Br J Clin Pract. 1987 Feb;41(2):619-24. PMID: 2960369.

5: HAYNES CE, MORRISON RD. Clinical comparison of ethoheptazine and aspirin with other analgesic combinations. J Oral Surg Anesth Hosp Dent Serv. 1961 Mar;19:114-21. PMID: 13712506.

6: CASS LJ, FREDERIK WS, BARTHOLOMAY AF. Methods in evaluating ethoheptazine and ethoheptazine combined with aspirin. J Am Med Assoc. 1958 Apr 12;166(15):1829-33. doi: 10.1001/jama.1958.02990150025006. PMID: 13525157.

7: Lamphier T, Rodriguez A, Richards D. Double-blind study of the analgesic effect of ethoheptazine-aspirin. Curr Ther Res Clin Exp. 1974 Jul;16(7):718-33. PMID: 4210461.

8: Overton DA, Batta SK. Investigation of narcotics and antitussives using drug discrimination techniques. J Pharmacol Exp Ther. 1979 Nov;211(2):401-8. PMID: 41087.

9: ALBERTSON GL. Clinical investigation of ethoheptazine citrate and acetylsalicylic acid as a postoperative analgesic in oral surgery. Oral Surg Oral Med Oral Pathol. 1959 Apr;12(4):438-41. doi: 10.1016/0030-4220(59)90055-6. PMID: 13644904.

10: Winter L Jr, Calman HI, Caruso WA, Post A. A double-blind comparison of ethoheptazine citrate, propoxyphene hydrochloride, and placebo. Curr Ther Res Clin Exp. 1973 Jul;15(7):383-90. PMID: 4198299.